News & Presentations Filter by Category All 75 Company News 28 Media 18 Newsletter 8 Presentations & Webinars 23 Newsletter, All Michelle Long 14/5/25 Newsletter, All Michelle Long 14/5/25 Arovella Newsletter May 2025 Read More Company News, Presentations & Webinars, All Michelle Long 8/5/25 Company News, Presentations & Webinars, All Michelle Long 8/5/25 EGM presentation and results Read More Media, All Michelle Long 6/5/25 Media, All Michelle Long 6/5/25 Stockhead What The Facts?! What are iNKT cell therapies? Read More Company News, All Michelle Long 5/5/25 Company News, All Michelle Long 5/5/25 ALA exclusive iNKT technology option with Baylor Read More Presentations & Webinars, All Michelle Long 30/4/25 Presentations & Webinars, All Michelle Long 30/4/25 Investor Webinar recording Read More Presentations & Webinars, All Michelle Long 17/4/25 Presentations & Webinars, All Michelle Long 17/4/25 Investor Webinar April 2025 Read More Media, All Michelle Long 17/4/25 Media, All Michelle Long 17/4/25 Stockhead Special Report: Arovella tackles CAR-T’s limitations in cancer treatment Read More Company News, All Michelle Long 15/4/25 Company News, All Michelle Long 15/4/25 Redkite Heartbreak to Hope Walk Read More Media, All Michelle Long 14/4/25 Media, All Michelle Long 14/4/25 Dr Michael Baker interviewed on Tim Boreham’s Health Kick Podcast Read More Company News, All Michelle Long 14/4/25 Company News, All Michelle Long 14/4/25 Extraordinary General Meeting (2025 EGM) Read More Presentations & Webinars, All Michelle Long 24/3/25 Presentations & Webinars, All Michelle Long 24/3/25 Spark Plus Singapore Healthcare Day 2025 Presentation Read More Company News, All Michelle Long 3/3/25 Company News, All Michelle Long 3/3/25 Research Agreement with University of North Carolina Read More Company News, All Michelle Long 3/3/25 Company News, All Michelle Long 3/3/25 Letter from Managing Director and CEO Read More Company News, All Michelle Long 26/2/25 Company News, All Michelle Long 26/2/25 Arovella fully funded to complete phase 1 enrolement and generate clinical data with $15 placement Read More Presentations & Webinars, All Michelle Long 4/2/25 Presentations & Webinars, All Michelle Long 4/2/25 Dr Michael Baker presents at the Euroz Hartleys 2025 Healthcare Forum Read More Media, All Michelle Long 28/1/25 Media, All Michelle Long 28/1/25 Proactive Investor: Oncology outlook: ASX small caps driving innovation in cancer treatment Read More Media, All Michelle Long 15/1/25 Media, All Michelle Long 15/1/25 Dr Michael Baker speaks with JustStocks about $20 million funding milestone Read More Company News, All Michelle Long 10/1/25 Company News, All Michelle Long 10/1/25 Arovella fully funded to complete phase 1 with $20m placement Read More Newsletter, All Michelle Long 19/12/24 Newsletter, All Michelle Long 19/12/24 Arovella Newsletter December 2024 Read More Media, All Michelle Long 9/12/24 Media, All Michelle Long 9/12/24 MST Access analyst coverage Read More Older Posts
Newsletter, All Michelle Long 14/5/25 Newsletter, All Michelle Long 14/5/25 Arovella Newsletter May 2025 Read More
Company News, Presentations & Webinars, All Michelle Long 8/5/25 Company News, Presentations & Webinars, All Michelle Long 8/5/25 EGM presentation and results Read More
Media, All Michelle Long 6/5/25 Media, All Michelle Long 6/5/25 Stockhead What The Facts?! What are iNKT cell therapies? Read More
Company News, All Michelle Long 5/5/25 Company News, All Michelle Long 5/5/25 ALA exclusive iNKT technology option with Baylor Read More
Presentations & Webinars, All Michelle Long 30/4/25 Presentations & Webinars, All Michelle Long 30/4/25 Investor Webinar recording Read More
Presentations & Webinars, All Michelle Long 17/4/25 Presentations & Webinars, All Michelle Long 17/4/25 Investor Webinar April 2025 Read More
Media, All Michelle Long 17/4/25 Media, All Michelle Long 17/4/25 Stockhead Special Report: Arovella tackles CAR-T’s limitations in cancer treatment Read More
Company News, All Michelle Long 15/4/25 Company News, All Michelle Long 15/4/25 Redkite Heartbreak to Hope Walk Read More
Media, All Michelle Long 14/4/25 Media, All Michelle Long 14/4/25 Dr Michael Baker interviewed on Tim Boreham’s Health Kick Podcast Read More
Company News, All Michelle Long 14/4/25 Company News, All Michelle Long 14/4/25 Extraordinary General Meeting (2025 EGM) Read More
Presentations & Webinars, All Michelle Long 24/3/25 Presentations & Webinars, All Michelle Long 24/3/25 Spark Plus Singapore Healthcare Day 2025 Presentation Read More
Company News, All Michelle Long 3/3/25 Company News, All Michelle Long 3/3/25 Research Agreement with University of North Carolina Read More
Company News, All Michelle Long 3/3/25 Company News, All Michelle Long 3/3/25 Letter from Managing Director and CEO Read More
Company News, All Michelle Long 26/2/25 Company News, All Michelle Long 26/2/25 Arovella fully funded to complete phase 1 enrolement and generate clinical data with $15 placement Read More
Presentations & Webinars, All Michelle Long 4/2/25 Presentations & Webinars, All Michelle Long 4/2/25 Dr Michael Baker presents at the Euroz Hartleys 2025 Healthcare Forum Read More
Media, All Michelle Long 28/1/25 Media, All Michelle Long 28/1/25 Proactive Investor: Oncology outlook: ASX small caps driving innovation in cancer treatment Read More
Media, All Michelle Long 15/1/25 Media, All Michelle Long 15/1/25 Dr Michael Baker speaks with JustStocks about $20 million funding milestone Read More
Company News, All Michelle Long 10/1/25 Company News, All Michelle Long 10/1/25 Arovella fully funded to complete phase 1 with $20m placement Read More
Newsletter, All Michelle Long 19/12/24 Newsletter, All Michelle Long 19/12/24 Arovella Newsletter December 2024 Read More
Media, All Michelle Long 9/12/24 Media, All Michelle Long 9/12/24 MST Access analyst coverage Read More
